Introduction
============

With the continuous change in modern lifestyles, the incidence rate of diabetes is on the rise ([@b1-mmr-16-06-8953]). Diabetic cardiomyopathy (DC) is a chronic complication of diabetes, a specific myocardial lesion independent from valvular heart disease, coronary heart disease, congenital heart disease and other diseases. Such disease is one of the major causes of death among diabetic patients ([@b2-mmr-16-06-8953]). The pathological changes of DC are mainly characterised by cardiomyocyte hypertrophy, apoptosis and necrosis as well as progressive myocardial interstitial fibrosis ([@b3-mmr-16-06-8953]). Myocardial fibrosis is an important marker of the myocardial remodelling of DC and the major cause of left ventricular dysfunction. Moreover, the mechanism involved is considerably complicated. Evidence shows that the pathogenesis of myocardial fibrosis is associated with oxidative stress, endoplasmic reticulum stress (ERS), apoptosis ([@b4-mmr-16-06-8953]--[@b8-mmr-16-06-8953]). However, the specific regulatory mechanism remains unclear.

Sulfur dioxide (SO~2~) is a poisonous, small-molecule gas. However, recent studies have found the existence of an endogenous SO~2~-generating system in the cardiovascular system. As a new gaseous signalling molecule following the discovery of NO, CO and hydrogen sulfide (H~2~S), endogenous SO~2~ performs the following functions: Vasodilation, suppression of inflammation and improvement of vascular collagen remodelling in the cardiovascular system ([@b9-mmr-16-06-8953]). However, whether SO~2~ takes part in the occurrence and development of DC and its internal mechanism remains an open issue.

As one of the prevalent cell signalling mechanisms of pathological and physiological processes in animals, the Hippo-MST signalling pathway participates in the regulation of cell proliferation and apoptosis ([@b10-mmr-16-06-8953]--[@b12-mmr-16-06-8953]). The components of the Hippo-MST pathway mainly include MST1/2, Sav, LATS1/2 and MOBI. MST1/2 is a protein kinase of the STE20 family and could phosphorylate the core members of the Hippo-MST pathway-Sav1, LATS1/2 and MOBI. At present, MST has been proven to play a role in regulating apoptosis in some animal models in the presence of cardiovascular diseases. It can also induce cell death by activating LATS. The upregulation of MST1 expression or its specific overexpression has been confirmed to induce the apoptosis of myocardial cells. The Hippo-MST pathway is also known to participate in the regulatory mechanism of myocardial fibrosis, and the overexpression of MST1 may result in myocardial fibrosis. However, the role of the Hippo-MST pathway in diabetic myocardial fibrosis and its mechanism of action remain unclear.

In the present research, we propose to establish an streptozotocin (STZ)-induced model of diabetic rats with intervention by a SO~2~ donor and endogenous SO~2~ synthase inhibitor L-Aspartic acid β-hydroxamate (HDX) so as to explore the role of the gaseous signalling molecule SO~2~ in inhibiting apoptosis by regulating the Hippo-MST pathway and improving ERS and myocardial fibrosis of diabetic rats.

Materials and methods
=====================

### Experimental animals

Adult male Sprague-Dawley (SD) rats (240±20 g) were obtained from the Animal Experiment Centre of South China University. Prior to the experiments, the SD rats were fed with standard rat chow and normal water *ad libitum*. The rats were housed and separated by treatment group under a 12 h light-dark cycle at a temperature of 23±1°C and humidity of 60%. The rats were fed according to institutional policies, and all the experiments were carried out with the approval of the University Committee on the Use and Care of Animals of South China University.

### Chemicals and reagents

Na~2~SO~3~, NaHSO~3~ and HDX were purchased from Sigma-Aldrich (St. Louis, MO, USA). STZ was purchased from MP Biomedicals, LLC (Santa Ana, CA, USA). The antibodies for matrix metalloproteinase (MMP)9, MMP24, tissue inhibitor of metalloproteinase (TIMP)1 and GAPDH were purchased from Wuhan Boster Biological Technology, Ltd. (Wuhan, China). The dilution rate of these antibodies was 1:400. Furthermore, the antibodies for MST1, MST2, MOB1, LATS1, BIP, PDI and ERO1-L were purchased from Cell Signalling Technology (Danfoss, MA, USA). The antibodies for Bcl-2, Bax, caspase-3, caspase-9, CHOP, GRP94, eIF2α and GOT1 were purchased from Proteintech Group, Inc. (Chicago, IL, USA). The dilution rate of these antibodies was 1:1,000. Anti-rabbit secondary antibody and anti-rat secondary antibody were also purchased from Proteintech Group, Inc. The cell lysis buffer for western blot analysis, Bicinchoninic Acid (BCA) Protein Assay kit, Enhanced Chemiluminescence Reagent kit and SDS-PAGE Gel Preparation kit were obtained from Beyotime Institute of Biotechnology (Shanghai, China). The ELISA kit of SO~2~ was obtained from Mlbio Co. (Shanghai, China).

### Model establishment and grouping

Forty experimental rats were randomly divided into four groups: Normal group (control group), diabetes mellitus rats (STZ 40 mg/kg) group (STZ group), diabetes mellitus rats (STZ 40 mg/kg) treated with SO~2~ (STZ+SO~2~ group) and diabetes mellitus rats (STZ 40 mg/kg) treated with HDX group (HDX group). Each rat in the STZ group, STZ+SO~2~ group and HDX group were made diabetic via a single intraperitoneal injection of 40 mg/kg body weight STZ. At the same time, the rats of the control group were treated with saline once (i.p.). Blood glucose from the rat tail vein was detected with a blood glucose monitor. The rats were considered diabetic when the concentration of glucose was higher than 16.7 mmol/l 3 days after STZ injection. Then, SO~2~ donor (Na~2~SO~3~/NaHSO~3~) was administered to the rats of the STZ+SO~2~ group. Na~2~SO~3~/NaHSO~3~ was freshly dissolved in saline at 0.54:0.18 mmol/kg before injection. The HDX group was treated with HDX (25 mg/kg, i.p.) once a week. The control group and STZ group were intraperitoneally injected with physiological saline every day. The experiment lasted for four weeks.

### Specimen collection and processing

After 4 weeks, the rats were weighed and subjected to echocardiography. They were then anesthetised with chloral hydrate (350 mg/kg). The hearts of the rats were lavaged with ice-cold normal saline before they were removed and weighed. Parts of the heart tissues were preserved at −80°C for the experiment. The remaining heart tissues were fixed in 4% paraformaldehyde in phosphate-buffered saline and then embedded in paraffin.

### Echocardiography analysis

After 4 weeks, the mice were anesthetised with chloral hydrate (350 mg/kg, i.p.). We used transthoracic echocardiography to test left ventricular function. The left ventricular end-diastolic dimension (LVEDD), left ventricular end-systolic diameter (LVESD), left ventricular ejection fraction (LVEF) and left ventricular fraction shortening (LVFS) were measured to evaluate heart function.

### Histopathology analysis of myocardial fibres

After 4 weeks, the animals that survived were sacrificed. Their hearts were removed immediately and then fixed in 4% paraformaldehyde. Each heart was embedded in paraffin, dewatered with alcohol, embedded in paraffin again and sliced up in 5 µm sections. These sections were stained using a Masson staining kit and observed under an optical microscope.

### SO~2~ content assay

Myocardial SO~2~ content was assayed by ELISA. The ELISA kit of SO~2~ was obtained from Mlbio Co. The steps were taken following the manufacturer\'s instructions.

### TUNEL assay

The myocardial tissue of each rat was fixed in 10% formalin and embedded in paraffin. It was then processed for TUNEL assay. The slides were treated with H~2~O~2~ and incubated with a reaction mixture containing TdT and digoxigenin-conjugated dUTP for 1 h at 37°C. Labelled DNA was visualised with a peroxidase-conjugated anti-digoxigenin antibody using 3,3′-diaminobenzidine (DAB) as the chromogen. Rat testicular tissue was used as positive control in the TUNEL assay.

### Transmission electron microscopy (TEM)

The left ventricular tissues in each group were cut into small pieces on the ice and then immersion-fixed in 2.5% glutaraldehyde, post-fixed in 1% osmium tetroxide and dehydrated in a series of graded ethanol solutions. Ultrathin sections were cut and stained with uranyl acetate and lead citrate. Ultrathin sections were observed via electron microscopy.

### Western blot analysis

Total proteins were extracted in ice-cold radioimmunoprecipitation assay buffer containing protease inhibitors (Beyotime Institute of Biotechnology) and then quantified using a BCA protein assay kit. Proteins were denatured, separated by SDS-PAGE electrophoresis and transferred to a PVDF membrane via wet transfer method. The membranes were blocked with 5% skimmed milk in Tris-buffered saline with Tween-20 (TBST) for 2 h at room temperature. The membranes were incubated with a blocking solution containing primary antibodies (anti-GAPDH, 1:400; anti-MMP9, 1:400; anti-MMP24, 1:400; anti-TIMP1, 1:400; anti-Bax, 1:1,000; anti-Bcl-2, 1:1,000; anti-caspase-3, 1:1,000; anti-caspase-9, 1:1,000; anti-GOT1, 1:1,000; anti-CHOP, 1:1,000; anti-GRP94, 1:1,000; anti-eIF2α, 1:1,000; anti-BIP, 1:1,000; anti-PDI, 1:1,000; anti-ERO1-L, 1:1,000; anti-MST1, 1:1,000; anti-MST2, 1:1,000; anti-MOB1, 1:1,000; anti-LATS1, 1:1,000) overnight at 4°C. After washing three times with TBST, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody (1:2,000) for 1 h at room temperature. Next, the membrane was washed in TBST buffer thrice. Finally, these membranes were subjected to chemiluminescence detection assay. The bands were analysed with a Molecular Imager VersaDoc MP 5000 system (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

### Statistical analysis

Data were expressed as mean ± standard deviation. The statistical differences among the groups were assessed via one-way analysis of variance with SPSS 18.0 (SPSS, Inc., Chicago, IL, USA). Comparisons between two groups were made using the Student-Newman-Keuls test. A P-value of \<0.05 was considered statistically significant.

Results
=======

### SO~2~ improves myocardial fibrosis in diabetic rats

Four weeks later, there were 10, 7, 9, 7 mice that had survived in the control group, STZ group, STZ+SO~2~ and HDX group respectively. In evaluating the deposition of collagen fibres in the myocardium, Masson staining was carried out at the end of the experiment. The result revealed the deposition of the collagen fibres. Blue staining demonstrated the intensity of myocardial fibrosis. As indicated by the result of Masson staining ([Fig. 1A](#f1-mmr-16-06-8953){ref-type="fig"}), myocardial fibrosis was barely observed in the control group. In the STZ group, the myocardial cells showed a disorderly arrangement, and myocardial fibres significantly increased. Unlike in the STZ group, the myocardial fibrosis was obviously alleviated in the STZ+SO~2~ group. Moreover, the myocardial fibrosis was more serious in the HDX group than in the STZ group. On the whole, these results above suggest that treatment with the SO~2~, decreases diabetes-induced myocardial fibrosis. Therefore, it indicates that SO~2~ improves myocardial fibrosis in diabetic rats.

### Effects of SO~2~ on MMP9, MMP24 and TIMP1 expression in diabetic rats

The balance of MMPs/TIMPs determines the ratio of collagen synthesis and degradation. Therefore, we determined the expressions of MMP9 ([Fig. 1B](#f1-mmr-16-06-8953){ref-type="fig"}), MMP24 ([Fig. 1C](#f1-mmr-16-06-8953){ref-type="fig"}) and TIMP1 ([Fig. 1D](#f1-mmr-16-06-8953){ref-type="fig"}) to reflect fibrosis to some degree. Compared with the control group, the expression levels of MMP9, MMP24 and TIMP1 in STZ group, STZ+SO~2~ group and HDX group were significantly increased. Compared with STZ group, the myocardial expression levels of MMP9, MMP24 and TIMP1 were significantly reduced in STZ+SO~2~ group, meanwhile, the expression levels of MMP9, MMP24 and TIMP1 were obviously increased in HDX group.

### SO~2~ improves cardiac function in diabetic rats

In this study, the parameters of cardiac function evaluated via echocardiography, namely, LVEDD, LVESD, ejection fraction (EF) and fractional shortening (FS), were measured to evaluate left ventricular function. Compared with the control group, LVEDD and LVESD increased more significantly in the STZ group and HDX group EF and FS decreased more significantly (by 17.32 and 13.5%, respectively) in the STZ group and (by 21.55 and 15.92%, respectively) HDX group. Compared with STZ group, the EF and FS increased more significantly in the STZ+SO~2~ group, while the LVEDD and LVESD obviously decreased in the STZ+SO~2~ group. Moreover, compared with STZ group, EF and FS slightly decreased in the HDX group, while the LVEDD and LVESD slightly increased in the HDX group, but there were not statistically significant ([Table I](#tI-mmr-16-06-8953){ref-type="table"}). Taken together, our results indicate that SO~2~ improves diabetic-induced the decrease of cardiac function.

### SO~2~ content in each group

To determine whether diabetes-induced myocardium damage was related to the decreased generation of endogenous SO~2~, we assayed SO~2~ content via ELISA. In comparison with those in the control group, the expression levels of SO~2~ in the STZ group and HDX group were significantly decreased. In comparison with that in the STZ group, the myocardial expression of SO~2~ was significantly increased in the STZ+SO~2~ group. Nevertheless, no significant changes were observed in the HDX group in comparison with the STZ group ([Fig. 2A](#f2-mmr-16-06-8953){ref-type="fig"}). The results demonstrate that the content of SO~2~ in diabetic rats were significantly decreased.

### GOT1 protein expressions in each group

The expressions of SO~2~ synthase aspartate aminotransferase (GOT1) protein in myocardium tissues were measured by western blot analysis. In comparison with that in the control group, the expression levels of GOT1 in the STZ group, STZ+SO~2~ group, and HDX group were significantly increased. In comparison with the STZ group, the myocardial expression of GOT1 was significantly decreased in the STZ+SO~2~ group. Nevertheless, no significant changes were observed in the HDX group in comparison with the STZ group ([Fig. 2B](#f2-mmr-16-06-8953){ref-type="fig"}).

### SO~2~ can reduce ERS in diabetic rats

By performing western blot analysis, we determined the expressions of CHOP ([Fig. 3A](#f3-mmr-16-06-8953){ref-type="fig"}), GRP94 ([Fig. 3B](#f3-mmr-16-06-8953){ref-type="fig"}), BIP ([Fig. 3C](#f3-mmr-16-06-8953){ref-type="fig"}), eIF2α ([Fig. 3D](#f3-mmr-16-06-8953){ref-type="fig"}), PDI ([Fig. 3E](#f3-mmr-16-06-8953){ref-type="fig"}) and ERO1-L ([Fig. 3F](#f3-mmr-16-06-8953){ref-type="fig"}) to observe ERS in the myocardium and to assess whether SO~2~ protects against ERS. Unlike those in the control group, the expressions of CHOP, eIF2α, GRP94, BIP, PDI and ERO1-L were significantly increased in the STZ group and HDX group. In comparison with those in the STZ group, the expression levels of CHOP, eIF2α, GRP94, BIP, PDI and ERO1-L in the STZ+SO~2~ group significantly decreased. The expression levels of some ERS protein markers slightly increased in the HDX group, but the change was not statistically significant. Our data thus indicate that SO~2~ inhibits the expression of proteins associated with ERS in diabetic rats.

### Effects of SO~2~ on myocardial ultrastructure in diabetic rats

To investigate the internal mechanism underlying the SO~2~-elicited beneficial effects against diabetes, we performed TEM in our observation of the endoplasmic reticulum and myocardial fibres. As indicated by the TEM results, the myocardial fibres were arranged normally, and the endoplasmic reticulum was normal and showed no swelling in the control group. In some myocardial tissues from the STZ group, the myocardial fibres were arranged disorderly and were dropsical, and focal cytolysis necrosis was observed. Swelling and vesiculation of the endoplasmic reticulum were also observed in the STZ group. These changes in the STZ group obviously improved in the STZ+SO~2~ group. Additionally, the myocardial ultrastructural changes in the HDX group were similar to those in the STZ group ([Fig. 4](#f4-mmr-16-06-8953){ref-type="fig"}). These results above indicates that SO~2~ improves the injury of myocardial ultrastructure in diabetic rats.

### SO~2~ can reduce cardiomyocyte apoptosis in diabetic rats

In this experiment, we used TUNEL assay to detect apoptosis in heart tissue. The number of apoptotic cells increased more obviously in the STZ group than in the control group. We also found that under SO~2~ treatment, the number of TUNEL-positive cells decreased obviously in the STZ+SO~2~ group. In comparison with those in the STZ group, the apoptotic cells in the HDX group obviously increased ([Fig. 5A](#f5-mmr-16-06-8953){ref-type="fig"}). These results indicate that SO~2~ suppresses diabetic-induced cell apoptosis indiabetic rats.

### SO~2~ can reduce myocardial apoptosis in diabetic rats

To expound the molecular basis of the increased myocardial apoptosis in the diabetic rats, we examined the expression levels of Bax ([Fig. 5B](#f5-mmr-16-06-8953){ref-type="fig"}), Bcl-2 ([Fig. 5C](#f5-mmr-16-06-8953){ref-type="fig"}), caspase-3 ([Fig. 5D](#f5-mmr-16-06-8953){ref-type="fig"}) and caspase-9 ([Fig. 5E](#f5-mmr-16-06-8953){ref-type="fig"}) via western blot analysis. The expressions of Bax, caspase-3 and caspase-9 expression increased, and the expression of Bcl-2 decreased in the STZ group in comparison with the control group. However, under SO~2~ treatment, the expression of Bcl-2 increased, and those of Bax, caspase-3 and caspase-9 decreased in the STZ+SO~2~ group in comparison with the STZ group. These results indicated that diabetes-induced apoptosis was likely mediated, at least in part, by the Bcl-2/Bax-mediated caspase-3 and caspase-9 activation pathway in the heart. Our results thus indicate that SO~2~ can reduce myocardial apoptosis in diabetic rats.

### Effects of SO~2~ on diabetes-induced change in the Hippo-MST signalling pathway

To demonstrate the Hippo-MST signalling pathway involved in the development of DC, we detected the expression of proteins related to the Hippo-MST signalling pathway via western blot analysis. In comparison with those in the control group, the expressions of MST1 ([Fig. 6A](#f6-mmr-16-06-8953){ref-type="fig"}), MST2 ([Fig. 6B](#f6-mmr-16-06-8953){ref-type="fig"}), MOB1 ([Fig. 6C](#f6-mmr-16-06-8953){ref-type="fig"}), and LATS1 ([Fig. 6D](#f6-mmr-16-06-8953){ref-type="fig"}) in the STZ group and HDX group significantly increased. In comparison with those in the STZ group, the expressions of MST1, MST2, MOB1 and LATS1 in STZ+SO~2~ group significantly decreased. Taken together, our results indicate that high glucose induced the activation of *Hippo-MST signalling pathway and* SO~2~ can downregulate the expression of proteins associated with Hippo-MST signalling pathway in diabetic rats.

Discussion
==========

Diabetic mellitus (DM) is a global health issue that has attracted significant attention. As one of the major complications of DM, DC imposes a severe threat on human health ([@b13-mmr-16-06-8953]). The crucial pathological changes of myocardial fibrosis in relation to the occurrence and development of DM are also an important cause of myocardial remodelling and heart failure. In this research, a model of diabetic rats was built with the intraperitoneal injection of STZ. Masson staining and TEM revealed that collagen deposition obviously increased in the myocardial tissue of the diabetic rats, and the western blot analysis indicated the significant maladjustment of MMPs/TIMPs in the myocardial tissue of the diabetic rats. The results suggest an obvious interstitial fibrosis in the myocardial tissue of the diabetic rats. Echocardiography also further confirmed the decline of cardiac function of the diabetic rats. Myocardial fibrosis participates in the mechanism of the occurrence and development of DC, and it is closely associated with the poor prognosis of diabetic patients. However, the mechanism of diabetic myocardial fibrosis has not been completely understood. Some studies have shown a close correlation between diabetic myocardial fibrosis and oxidative stress, ERS, apoptosis.

Currently, apoptosis is known to take part in the occurrence and development of DC ([@b14-mmr-16-06-8953],[@b15-mmr-16-06-8953]). When the body is under common apoptosis-promoting stimulations of diabetes, such as high glucose, oxidative stress and metabolic disorders, the caspase cascade pathways in the myocardial tissue are activated one by one, thus inducing the occurrence of apoptosis. The activation of caspase-3 is a key link in the apoptosis signalling pathway ([@b16-mmr-16-06-8953]), and Bcl-2 has been proven to block the activation of caspase and inhibit cell apoptosis ([@b17-mmr-16-06-8953]). The result of TUNEL staining revealed that the number of apoptotic cells in the myocardial tissues of the diabetic rats increased more remarkably relative to the control group. At the same time, the expressions of the pro-apoptotic proteins caspase-3, caspase-9 and Bax in the myocardial tissue was significantly upregulated, and the expression of the anti-apoptotic protein Bcl-2 was obviously downregulated. ERS has been also found to take part in the occurrence mechanism of DC, and it serves as the initial common channel of oxidative stress and other cell stress reactions. However, sustained or extremely strong ERS may result in cell apoptosis. ERS in diabetics may be induced by numerous factors, including hyperglycemia, oxidative stress, activation of RAS system and lipid metabolism. Some studies have found that ERS in myocardial cells is excessively activated ([@b18-mmr-16-06-8953],[@b19-mmr-16-06-8953]). The current research found that the ERS-associated proteins of DC, such as CHOP, GRP94, BIP and eIF2α, were obviously upregulated. Furthermore, TEM showed that swelling occurred in the endoplasmic reticulum of the myocardial cells and that the volume increased, thereby suggesting excessively activated ERS in the myocardial tissue as well as endoplasmic reticulum damage. ERS may activate CHOP, and the upregulation of CHOP may inhibit Bcl-2 expression, thus inducing ERS-associated apoptosis. In the present work, we found that the endoplasmic reticulum was obviously activated in the myocardial tissues of the diabetic rats and that CHOP expression was upregulated, thereby suggesting that ERS participated in the occurrence mechanism of apoptosis in the process of diabetic myocardial fibrosis.

As one of the prevalent cell signalling mechanisms of pathological and physiological processes in animals, the Hippo-MST signalling pathway participates in the regulation of cell proliferation and apoptosis, tissue repair and other processes ([@b20-mmr-16-06-8953]). Such pathway mainly includes MST, MOB, LATS and other signalling molecules. As a key transcription factor of this pathway, MST1 plays an important role in promoting cell apoptosis and proliferation ([@b21-mmr-16-06-8953],[@b22-mmr-16-06-8953]). Activated MST may enter the cell nucleus to promote apoptosis, inhibit cell growth and proliferation and associate with the phosphorylation of FOXO. LATS may be activated by the phosphorylation of MST, enter its own phosphorylation cycle and become activated continuously. MST and LATS can also interact with each other to create a positive feedback circuit and thus promote the pro-apoptotic effect. Some studies have shown that MST1 overexpression may promote myocardial apoptosis and that the inhibition of MTS1 expression may improve apoptosis as well as myocardial remodelling and cardiac dysfunction caused by destructive stimuli, such as apoptosis and ischaemia-reperfusion injury ([@b23-mmr-16-06-8953]--[@b26-mmr-16-06-8953]). The latest research shows that the abnormal activation of MST1 is closely associated with the occurrence mechanism of diabetes and that it participates in the occurrence of myocardial fibrosis ([@b27-mmr-16-06-8953],[@b28-mmr-16-06-8953]). In the current research, we found obvious myocardial fibrosis in the diabetic rats and a remarkably upregulated expression of the Hippo-MST pathway-associated proteins. Such finding suggests the possible participation of the Hippo-MST pathway in the occurrence of myocardial fibrosis in the diabetic rats. MST1/2 may phosphorylate the core members of Hippo signalling, namely, Sav1, LATS1/2 and MOB1. Therefore, the upregulation of MST1/2 may promote apoptosis. In the present research, we found that the expressions of MST1/2 and its downstream pathway proteins MOB and LATS were obviously upregulated. The expressions of MST1/2 and its downstream pathway proteins MOB and LATS may participate in apoptosis regulation under oxidative stress and ERS in diabetics. Hence, the Hippo-MST signalling pathway maintains the balance between tissue injury and repair and participates in the occurrence mechanism of diabetic myocardial fibrosis by regulating cell apoptosis and maintaining proliferation.

After the discovery of NO, CO and H~2~S in recent years, some studies have shown that SO~2~ may be a novel gaseous signalling molecule ([@b29-mmr-16-06-8953]). As the research on sulfurous gases continue, an endogenous SO~2~-generating system has been found in the cardiovascular system. Sulfur-containing amino acids may generate H~2~S and SO~2~ via in vivo metabolism ([@b30-mmr-16-06-8953],[@b31-mmr-16-06-8953]). Thus far, H~2~S is known to exhibit a myocardial protective effect in the presence of oxidative stress and hypoxic-ischaemic injury and improve myocardial fibrosis. Both H~2~S and SO~2~ are metabolites of sulfur-containing amino acids, and their pathological actions closely correlated with each other. Recent studies have found that SO~2~ improved the ISO-induced myocardial apoptosis of the rats ([@b32-mmr-16-06-8953]). Some studies have shown that SO~2~ gas performs many biological functions, such as vasodilation, improvement of vascular and collagen remodelling; it also inhibits inflammation and autoxidation and exerts an important protective effect on vascular diseases ([@b33-mmr-16-06-8953]--[@b36-mmr-16-06-8953]), such as pulmonary arterial hypertension, myocardial ischaemia-reperfusion injury, myocardial hypertrophy, spontaneous hypertension and acute lung injury ([@b37-mmr-16-06-8953]--[@b40-mmr-16-06-8953]). However, the role of SO~2~ in diabetic myocardial fibrosis and the relevant regulatory mechanism have not been studied yet. The result of the present research indicated that after the intervention with SO~2~ donor, collagen deposition was obviously decreased in the myocardial interstitium of the diabetic rats and that the dysregulation of MMPs/TIMPs obviously improved, thus suggesting that exogenous SO~2~ could improve the myocardial fibrosis of diabetic rats. The ERS level in the myocardial tissue of the diabetic rats obviously decreased after the intervention with SO~2~. The result showed that the expressions of ERS-associated proteins CHOP, GRP94, eIF2α, BIP, PDI and ER01-L were obviously downregulated. Furthermore, after the intervention with SO~2~, cell apoptosis obviously decreased in the myocardial cells of the diabetic rats. At the same time, the expressions of the pro-apoptotic proteins caspase-3 and caspase-9 were obviously downregulated, and the expression of the anti-apoptotic protein Bcl-2 was obviously upregulated. Such findings indicate that exogenous SO~2~ can improve ERS and inhibit cell apoptosis, which may be associated with its role in improving myocardial fibrosis.

Existing studies have found that the role of SO~2~ in inhibiting cell apoptosis may be correlated with its mechanism of regulating the Hippo-MST signalling pathway. The expressions of the Hippo-MST signalling pathway proteins (MST1, Sav1, LATS1 and MOB1) in the myocardial tissues of the rats in the SO~2~ intervention group were obviously downregulated in comparison with those in the diabetic group. Hence, exogenous SO~2~ may inhibit the Hippo-MST signalling pathway to reduce ERS and cell apoptosis as well as the resulting diabetic myocardial fibrosis. On the contrary, after the intervention with the SO~2~-generating enzyme inhibitor HDX, the myocardial fibrosis of the diabetic rats became severe in Masson staining, but he myocardial ultrastructural changes in the HDX group were similar to those in the STZ group, It is likely to have some factors that was difficult to control, because we can not make sure the myocardial tissues were obtained from the identical parts in the heart and there may be some differences between Masson staining and TEM in the steps of making myocardium specimens, we need to evaluate the difference of myocardial fibrosis between STZ group and HDX group in multiple aspects. For example, compared with STZ group, the expression levels of MMP9, MMP24 and TIMP1 were obviously increased and the cardiac function was even worse in HDX group, these results remind us that the myocardial fibrosis may become severe in HDX group, thus suggesting that endogenous SO~2~ may take part in the regulatory mechanism of myocardial fibrosis in diabetic rats. Unlike that in the diabetics group, the intervention with HDX led to no statistically significant changes in the Hippo-MST signalling pathway, ERS and apoptosis in the myocardial tissues of the diabetic rats. Hence, the aforementioned changes in diabetic myocardial tissue may be related to the downregulated generation of endogenous SO~2~ and its signal regulation.

In the present research, the downregulated generation of endogenous SO~2~ wasobserved in DC. This result corresponded to the compensatory upregulation of the expression of the endogenous SO~2~-generating enzyme GOT1, thereby suggesting that the insufficient endogenous generation of the gaseous signalling molecule SO~2~ may contribute to the occurrence mechanism of myocardial interstitial fibrosis in diabetic rats and that the internal mechanism by which SO~2~ improves myocardial fibrosis may be associated with its inhibition of the Hippo-MST signalling pathway to improve cell apoptosis and ERS. The above results would provide new evidence for the further discussion on the occurrence mechanism of DC and offer a new target for the treatment and prevention of diabetic myocardial fibrosis. However, the specific molecular mechanism by which endogenous SO~2~ regulates the Hippo-MST signalling pathway and improves cell fate still need further discussion because of the limitations of present data, We planed to do further research about the specific molecular mechanism by which endogenous SO~2~ regulates the Hippo-MST signalling pathway and improves cell fate on the basis of present results in the next research, such as adding the SO~2~ treatment group on normal rats and MST inhibitor treatment group on STZ-induced diabetic rats and useing cell culture to explore the role of Hippo-MST signalling pathway in high glucose-induced cardiomyocyte injury and whether SO~2~ protects cardiomyocytes against high glucose-induced injury by Hippo-MST signalling pathway by. In order to discuss the specific relation among ERS, apoptosis and Hippo-MST signalling pathway, it is important to conduct enzymatic activity assays and reporter gene assays. Meanwhile, we intended to use Mst1-knockout mice to investigate Mst1-knockout whether can alleviate the myocardial fibrosis in DC. We hope the further research to make more contributions to the treatment of DC.
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![SO~2~ improves myocardial fibrosis in diabetic rats. (A) Morphological changes in myocardium assessed by Masson staining. Images were acquired at ×400 magnification. Expression levels of (B) MMP9, (C) MMP24 and (D) TIMP1 in each group. Date are expressed as mean ± standard deviation (n=3). \*P\<0.05 vs. control group; ^\#^P\<0.05 vs. STZ group. SO~2~, sulfur dioxide; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase; STZ, streptozotocin; HDX, L-Aspartic acid β-hydroxamate.](MMR-16-06-8953-g00){#f1-mmr-16-06-8953}

![(A) Quantification of myocardial SO~2~ content in rats from each group and SO~2~ synthase aspartate aminotransferase (GOT1) protein expressions in each group (B) Data are expressed as mean ± standard deviation (n=3). \*P\<0.05 vs. control group; ^\#^P\<0.05 vs. STZ group. SO~2~, sulfur dioxide; STZ, streptozotocin; HDX, L-Aspartic acid β-hydroxamate.](MMR-16-06-8953-g01){#f2-mmr-16-06-8953}

![SO~2~ can reduce endoplasmic reticulum stress in diabetic rats. Expression levels of (A) CHOP, (B) GRP94, (C) BIP, (D) eIF2α, (E) PDI and (F) ERO1-L in each group. Data are expressed as mean ± standard deviation (n=3). \*P\<0.05 vs. control group; ^\#^P\<0.05 vs. STZ group. SO~2~, sulfur dioxide; STZ, streptozotocin; HDX, L-Aspartic acid β-hydroxamate.](MMR-16-06-8953-g02){#f3-mmr-16-06-8953}

![SO~2~-alleviated myocardial ultrastructural disorder and swelling of the endoplasmic reticulum in diabetic rats. Transmission electron micrographs at bars of 1 and 2 µm. SO~2~, sulfur dioxide; STZ, streptozotocin.](MMR-16-06-8953-g03){#f4-mmr-16-06-8953}

![SO~2~ reduces cardiomyocyte apoptosis in diabetic rats. (A) Representative photomicrographs of heart tissues showing TUNEL-positive (apoptotic) myocardiocytes. Images were acquired at ×400 magnification. Expression levels of (B) Bax, (C) Bcl-2, (D) caspase-3 and (E) caspase-9 in each group. Data are expressed as mean ± standard deviation (n=3). \*P\<0.05 vs. control group; ^\#^P\<0.05 vs. STZ group. SO~2~, sulfur dioxide; STZ, streptozotocin; HDX, L-Aspartic acid β-hydroxamate.](MMR-16-06-8953-g04){#f5-mmr-16-06-8953}

![Effects of SO~2~ on diabetes-induced change in Hippo-MST signalling pathway. Expression levels of (A) MST1, (B) MST2, (C) MOB1 and (D) LATS1 in each group. Data are expressed as mean ± standard deviation (n=3). \*P\<0.05 vs. control group; ^\#^P\<0.05 vs. STZ group. SO~2~, sulfur dioxide; STZ, streptozotocin; HDX, L-Aspartic acid β-hydroxamate.](MMR-16-06-8953-g05){#f6-mmr-16-06-8953}

###### 

SO~2~ improves cardiac function in diabetic rats. Effects of SO~2~ on LVEDD, LVESD, EF and FS% in diabetic rats.

  Group        control group   STZ group                                                    STZ+SO~2~ group                                              HDX group
  ------------ --------------- ------------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------------------------
  LVEDD (mm)   4.77±0.59       6.27±0.32^[a](#tfn2-mmr-16-06-8953){ref-type="table-fn"}^    5.26±0.31^[b](#tfn3-mmr-16-06-8953){ref-type="table-fn"}^    6.50±0.42^[a](#tfn2-mmr-16-06-8953){ref-type="table-fn"}^
  LVESD (mm)   2.50±0.18       4.17±0.21^[a](#tfn2-mmr-16-06-8953){ref-type="table-fn"}^    3.10±0.26^[b](#tfn3-mmr-16-06-8953){ref-type="table-fn"}^    4.56±0.71^[a](#tfn2-mmr-16-06-8953){ref-type="table-fn"}^
  EF (%)       85.35±2.27      68.03±0.90^[a](#tfn2-mmr-16-06-8953){ref-type="table-fn"}^   79.40±1.56^[b](#tfn3-mmr-16-06-8953){ref-type="table-fn"}^   63.80±3.68^[a](#tfn2-mmr-16-06-8953){ref-type="table-fn"}^
  FS (%)       46.27±2.73      32.77±1.46^[a](#tfn2-mmr-16-06-8953){ref-type="table-fn"}^   41.57±1.43^[b](#tfn3-mmr-16-06-8953){ref-type="table-fn"}^   30.35±2.62^[a](#tfn2-mmr-16-06-8953){ref-type="table-fn"}^

Values are expressed as mean ± standard deviation (n=7).

P\<0.05 vs. control group

P\<0.05 vs. STZ group. SO~2~, sulfur dioxide; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic diameter; EF, ejection fraction; FS, fractional shortening; STZ, streptozotocin; HDX, L-Aspartic acid β-hydroxamate.
